Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Trends in Enzyme Inhibition and Activation in Drug Design – Part-I

Author(s): Athina Geronikaki

Volume 19, Issue 4, 2019

Page: [244 - 245] Pages: 2

DOI: 10.2174/156802661904190411090238

« Previous Next »
[1]
Eleftheriou, P.; Geronikaki, A.; Petrou, A. PTP1B inhibition, A promising approach for the treatment of diabetes type II. Curr. Topics. Med. Chem., 2019, 19(4), 246-263. [PMID: 30714526].
[2]
Saxena, M.; Dubey, R. Target enzyme in Alzheimer’s disease: Acetylcholinesterase inhibitors. Curr. Topics. Med. Chem., 2019, 19(4), 264-275. [PMID: 30706815].
[3]
Rekka, E.A.; Kourounakis, P.N.; Pantelidou, M. Xenobiotic metabolising enzymes: Impact on pathologic conditions, drug interactions and drug design. Curr. Topics. Med. Chem., 2019, 19(4), 276-291. [PMID: 30706817].
[4]
Merlani, M.; Barbakadze, V.; Amiranashvili, L.; Gogilashvili, L.; Poroikov, V.; Petrou, A.; Geronikaki, A.; Ciric, A.; Glamoclija, J.; Sokovic, M. New caffeic acid derivatives as antimicrobial agents: Design, synthesis, evaluation and docking. Curr. Topics. Med. Chem., 2019, 19(4), 292-304. [PMID: 30674263].
[5]
Shaik, A.; Agarwal, H.K.; Bhakuni, R.; Kirubakaran, S. Novel pyrazolo[4, 3-c]quinolin-3-one derivatives as PDE5A inhibitors. Curr. Topics. Med. Chem., 2019, 19(4), 305-315. [PMID: 30747070].

Rights & Permissions Print Cite
Article Metrics
30
1
© 2025 Bentham Science Publishers | Privacy Policy